Omeprazole and clopidogrel: Should clinicians be worried?

被引:27
作者
Depta, Jeremiah P. [2 ]
Bhatt, Deepak L. [1 ,3 ,4 ,5 ]
机构
[1] VA Boston Healthcare Syst, Boston, MA 02132 USA
[2] Cleveland Clin, Inst Med, Dept Internal Med, Cleveland, OH 44106 USA
[3] Brigham & Womens Hosp, Integrated Intervent Cardiovasc Program, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA USA
[5] TIMI Study Grp, Boston, MA USA
关键词
PROTON PUMP INHIBITORS; TRIAL; PANTOPRAZOLE; ASPIRIN; THERAPY; RISK;
D O I
10.3949/ccjm.77a.09173
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The US Food and Drug Administration has issued a warning that omeprazole (Prilosec) reduces the antiplatelet activity of clopidogrel (Plavix) by about 50%. However, the warning is based largely on ex vivo data. Preliminary results from a randomized clinical trial revealed no effect on cardiovascular outcomes when omeprazole was given with clopidogrel. We recommend that physicians continue to prescribe a proton pump inhibitor for patients receiving dual antiplatelet therapy who are at risk of gastrointestinal bleeding or have an indication for use of a proton pump inhibitor.
引用
收藏
页码:113 / 116
页数:4
相关论文
共 20 条
[1]  
AUBERT RE, 2008, CIRCULATION S, V118
[2]   ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents [J].
Bhatt, Deepak L. ;
Scheiman, James ;
Abraham, Neena S. ;
Antman, Elliott M. ;
Chan, Francis K. L. ;
Furberg, Curt D. ;
Johnson, David A. ;
Mahaffey, Kenneth W. ;
Quigley, Eamonn M. ;
Harrington, Robert A. ;
Bates, Eric R. ;
Bridges, Charles R. ;
Eisenberg, Mark J. ;
Ferrari, Victor A. ;
Hlatky, Mark A. ;
Kaul, Sanjay ;
Lindner, Jonathan R. ;
Moliterno, David J. ;
Mukherjee, Debabrata ;
Schofield, Richard S. ;
Rosenson, Robert S. ;
Stein, James H. ;
Weitz, Howard H. ;
Wesley, Deborah J. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (18) :1502-1517
[3]  
BHATT DL, 2009, TRANSC CARD THER SEP
[4]   Comparison of Omeprazole and Pantoprazole Influence on a High 150-mg Clopidogrel Maintenance Dose The PACA (Proton Pump Inhibitors And Clopidogrel Association) Prospective Randomized Study [J].
Cuisset, Thomas ;
Frere, Corinne ;
Quilici, Jacques ;
Poyet, Raphael ;
Gaborit, Benedicte ;
Bali, Laurent ;
Brissy, Olivier ;
Morange, Pierre-Emmanuel ;
Alessi, Marie-Christine ;
Bonnet, Jean-Louis .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (13) :1149-1153
[5]   Aspirin and platelet adenosine diphosphate receptor antagonists in acute coronary syndromes and percutaneous coronary intervention - Role in therapy and strategies to overcome resistance [J].
Depta, Jeremiah P. ;
Bhatt, Deepak L. .
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2008, 8 (02) :91-112
[6]  
Dunn SP, 2008, CIRCULATION, V118, pS815
[7]   Overprescribing proton pump inhibitors - Is expensive and not evidence based [J].
Forgacs, Ian ;
Loganayagam, Aathavan .
BMJ-BRITISH MEDICAL JOURNAL, 2008, 336 (7634) :2-3
[8]   Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin [J].
Gilard, Martine ;
Arnaud, Bertrand ;
Cornily, Jean-Christophe ;
Le Gal, Gregoire ;
Lacut, Karine ;
Le Calvez, Genevive ;
Mansourati, Jacques ;
Mottier, Dominique ;
Abgrall, Jean-Francois ;
Boschat, Jacques .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (03) :256-260
[9]   Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome [J].
Ho, P. Michael ;
Maddox, Thomas M. ;
Wang, Li ;
Fihn, Stephan D. ;
Jesse, Robert L. ;
Peterson, Eric D. ;
Rumsfeld, John S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (09) :937-944
[10]   A population-based study of the drug interaction between proton pump inhibitors and clopidogrel [J].
Juurlink, David N. ;
Gomes, Tara ;
Ko, Dennis T. ;
Szmitko, Paul E. ;
Austin, Peter C. ;
Tu, Jack V. ;
Henry, David A. ;
Kopp, Alex ;
Mamdani, Muhammad M. .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2009, 180 (07) :713-718